| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |